UPC Opt-Out Client Portal

HGF’s bespoke UPC Opt-out portal has been designed and developed by HGF to assist clients when providing us with their instructions on the opt-out of their European patents and applications. The portal sits within HGF’s online client information portal, OCIS. Each client has a unique and secure login which provides access to their company patent schedule for all patent cases that are eligible for the UPC opt-out. The portal enables clients to review and submit information to HGF in order for us to file an opt-out application on our client’s behalf, creating a streamlined process. The portal also provides real-time access on the decisions you have made on your opt-out history and is accessible 24/7.

Once access is granted there is a video available to show you how to navigate and use the portal. If you would like more information please contact Tara Cooney in our UPC ready team.

Latest updates

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article

UPC on Doctrine of Equivalents

Plant-e Knowledge BV & anor v Arkyne Technologies SL UPC_CFI_239/2023 (Brinkman, Granata, Walker & Koke) – 22 November 2024 The Hague Local Division has handed down the first substantive UPC …

Read article

UPC stakes claim for wide-reaching long-arm jurisdiction for European patents

Fujifilm Corporation v Kodak GmbH & ors – Thomas J, Dr Thom J and Dr Parchmann J.  – UPC_CFI_355/2023 –  28 January 2025 The Düsseldorf Local Division has delivered the …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

With the EPO and UPC adopting different frameworks for inventive step, is there potential for conflicting decisions?

The EPO regularly applies the problem and solution approach when deciding whether an invention involves an inventive step.  Central to this approach is identifying the technical differences between the invention …

Read article

Paris Central Division of the UPC has provided guidance on what constitutes common general knowledge (“CGK”)

Netherlands B.V. v VMR Products LLC [UPC_CFI_307/2023] –Paris Central Division (Catalozzi, Zhilova, Tillmann) – 29 November 2024 The Paris Central Division of the UPC has provided guidance on what constitutes …

Read article

UPC Court of Appeal Remits Meril’s request to stay infringement proceedings pending the outcome of EPO opposition

Meril Life Sciences PVT Limited & ors v Edwards Lifesciences Corporation [UPC-CoA-551/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé) – 21 November 2024 The UPC’s First Panel of …

Read article

Central Division takes pragmatic approach to late-filed submissions and revokes VMR’s patent for lack of inventive step

In Njoy v VMR (UPC_CFI_308/2023), the Paris Central Division confirmed that the “front loaded” provisions of the UPC should be interpreted in line with the principles of proportionality and procedural …

Read article